965.80+19.3 (+2.04%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Orchid Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Orchid Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Reg. 34 (1) Annual Report8 Sept 2026
    Reg. 34 (1) Annual Report.
    Annual Report of the Company for FY 2025-26.
  2. Business Responsibility and Sustainability Reporting (BRSR)8 Sept 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report for FY 2025-26
  3. Change in Management3 Sept 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of cost auditor for FY 2026-27 and change in designation of director.
  4. Outcome without intimation3 Sept 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board meeting.
  5. Analyst / Investor Meet21 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of the Analyst/Investor Earning Call for Q-1 ended on June 30, 2026
  6. Analyst / Investor Meet17 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30, 2026.
  7. Reg. 32 (1), (3) - Statement of Deviation & Variation14 Aug 2026
    Statement Of Deviation Or Variation For The Quarter Ended June 30, 2026 On The Use Of Proceeds Of Funds Raised Through Qualified Institutional Placement
    Statement of Deviation or variation for the quarter ended June 30, 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.
  8. Monitoring Agency Report14 Aug 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Monitoring Agency Report for Quarter-1 of F.Y. 2026-27 ended June 30, 2026.
  9. General14 Aug 2026
    Outcome Of Board Meeting Held For Considering And Approving Revised Audited Financial Results For The Year Ended March 31, 2026 Pursuant To Scheme Of Merger.
    Revised Audited financial results for the Financial year ended March 31, 2026 pursuant to Scheme of Merger
  10. Outcome of Board Meeting14 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27, ended on June 30, 2026.
  11. Board Meeting11 Aug 2026
    Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 14, 2026.
    Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Limited reviewed financial ....
  12. Allotment of Equity Shares1 Aug 2026
    Announcement under Regulation 30 (LODR)-Allotment
    Intimation under regulation 30- Update on scheme of Amalgamation
  13. Outcome of Board Meeting1 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On August 01, 2026
    Outcome of Board Meeting held on August 01, 2026
  14. General25 Jul 2026
    Intimation Regarding Investor Roadshow
    Intimation regarding Investor Roadshow
  15. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201811 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Confirmation certificate under Regulation 74(5) of Securities and Exchange board of India (Depositories and Participants) Regulations, 2018.
  16. Record Date10 Jul 2026
    Corporate Action For Fixation Of Record Date
    Fixation of Record Date pursuant to scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited for alloting shares to Shareholders of Dhanuka Laboratories Limited
  17. Amendments to Memorandum & Articles of Association10 Jul 2026
    Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
    Outcome of Board Meeting: Amendment in the Capital Clause of Memorandum of Association of Company pursuant to the effectiveness of Scheme of Amalgamation of Dhanuka Laboratories Limited ....
  18. Outcome without intimation10 Jul 2026
    Board Meeting Outcome for Intimation Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ("SEBI Listing Regulations").
    Outcome of the Board Meeting
  19. General10 Jul 2026
    Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited ('Amalgamating Company') With Orchid Pharma Limited ('Amalgamated Company/Company') And Their Respective Shareholders
    Update related to the Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Amalgamated Company/Company") and their respective Shareholders ....
  20. Press Release / Media Release7 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Announcement under Regulation 30 regarding the licensing and supply agreement with Pharmasyntez JSC, Russia

Frequently Asked Questions

Where can I download the annual report of Orchid Pharma Ltd.?
Annual reports of Orchid Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Orchid Pharma Ltd.?
Quarterly earnings results and presentations of Orchid Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Orchid Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Orchid Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Orchid Pharma Ltd.?
Investor presentations and annual day presentations of Orchid Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Orchid Pharma Ltd.?
Corporate announcements and regulatory filings of Orchid Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Orchid Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Orchid Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Orchid Pharma Ltd.?
The ISIN (International Securities Identification Number) of Orchid Pharma Ltd. is INE191A01027. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Orchid Pharma Ltd. listed?
Orchid Pharma Ltd. is listed on NSE and BSE. The NSE symbol is ORCHPHARMA and the BSE code is -.
Where can I find the shareholding pattern of Orchid Pharma Ltd.?
The quarterly shareholding pattern of Orchid Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Orchid Pharma Ltd. on Sharpely?
Share price data for Orchid Pharma Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.